LFA
SPPI

Legacy Financial Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Legacy Financial Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-24
Closed – – 961
2019
Q1 		$0 Hold
24
– – ﹤0.01% 1171
2018
Q4 		$0 Hold
24
– – ﹤0.01% 1059
2018
Q3 		$0 Hold
24
– – ﹤0.01% 963
2018
Q2 		$1K Hold
24
– – ﹤0.01% 905
2018
Q1 		$0 Hold
24
– – ﹤0.01% 923
2017
Q4 		$0 Buy
+24
New +$435 ﹤0.01% 868

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legacy Financial Advisors's SPPI Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 24 shares.

Legacy Financial Advisors first reported a position in SPPI in Q4 2017 and held it in 6 quarters. The position peaked at $1K in Q2 2018. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

  • Legacy Financial Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Legacy Financial Advisors sold 24 Spectrum Pharmaceuticals Inc shares in Q2 2019.
  • Legacy Financial Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 6 quarters.
  • Legacy Financial Advisors's Spectrum Pharmaceuticals Inc position peaked at $1K in Q2 2018.
  • 165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.